All stocks
$ 1,510.00 ARS+8.63%LAST CLOSE · ARS · Oct 02, 2026

A pharmaceutical laboratory developing, manufacturing and marketing medicines across therapeutic areas.

Market capitalisation≈ 121.93B ARSMarket value of the company’s shares
Price / earnings (P/E)≈ 10.72×Price relative to 12-month earnings
Forward P/ENot availablePrice relative to forecast earnings
Dividend yield≈ 2.16%Dividends relative to the share price
LAST CLOSE · ARS

$ 1,510.00

-2.58%over 1M · Oct 02, 2026
Price history
Source: BYMA Open Data · Daily bars · T+1 settlement

Price data table

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · BYMA · ARS · 1M
DateOpenHighLowCloseVolume
1,3701,5751,3701,51020,604
1,4101,4101,3401,3906,355
1,3801,4451,3801,4351,240
1,4351,4351,4001,4055,359
1,4901,5001,3601,4405,318
1,5651,5651,4951,5102,196
1,5151,5801,4951,51010,447
1,5501,5901,5051,5207,769
1,5401,5951,5401,575349
1,5451,5901,5451,560914
1,5701,6001,5401,54086
1,5401,6051,5401,590348
1,5351,6051,5351,550374
1,6201,6201,5351,5658,455
1,5351,5951,5051,5751,851
1,5551,5951,5551,565394
1,5551,6051,5401,565703
1,5401,6251,5201,5851,501
1,5601,5951,5101,5455,120
1,5551,6351,5301,5452,286
1,5551,5901,5551,5853,631
1,5851,5901,5551,5601,635
1,5551,5851,5551,5851,189
1,5501,6001,5301,5501,659

Daily BYMA observations for the selected period, newest first. Prices are in ARS. “—” means missing data; zeros are retained even when not plotted. Dates use Buenos Aires time.

The business

Laboratorios Richmond develops, manufactures and markets medicines across therapeutic areas. Products combine formulation, controlled manufacturing and access to healthcare channels. Patients, prescribers and purchasers can be different parties, so medical demand, commercial sales and receipts need not coincide.

Latest fiscal year

Fiscal year 2025Period end:

Revenue
≈ 126.73B ARS
Net income
≈ 2.4B ARS
Total assets
≈ 421.39B ARS
Total debt
≈ 246.38B ARS
THE BUSINESS, EXPLAINED

About Laboratorios Richmond

A pharmaceutical laboratory developing, manufacturing and marketing medicines across therapeutic areas.

Laboratorios Richmond combines drug development, manufacturing and marketing. Its therapeutic portfolio connects research and production capabilities with healthcare demand.

Exchange
BYMA
Local symbol
RICH
Business areas
1

Business economics · explained by La Plata

Customers, operations & revenue

Laboratorios Richmond develops, manufactures and markets medicines across therapeutic areas. Products combine formulation, controlled manufacturing and access to healthcare channels. Patients, prescribers and purchasers can be different parties, so medical demand, commercial sales and receipts need not coincide.

What shapes business performance

Medicine mix, inputs, plant utilisation and development spending affect profitability. New facilities or projects require capital ahead of sales. Announced capacity, approved products and actual commercial production should be distinguished, alongside inventory and collection periods.

Products, services & businesses

Pharmaceuticals

Laboratorios Richmond develops, manufactures and markets medicines across therapeutic areas. Laboratory and manufacturing capabilities connect with healthcare buyers; approvals, quality and supply continuity accompany the product throughout its lifecycle.

Who it serves
Professionals, distributors and institutions in human or animal health, depending on the product.
How the business works
Development and manufacturing must meet technical and approval requirements. Commercial activity combines a product portfolio, distribution channels and production capacity.

The business in practice

Selected products, companies and assets from corporate publications.

A portfolio spanning therapeutic areas

Richmond presents infectious-disease, oncology and oncohaematology, cardiometabolic and neuroscience lines. They address different needs of patients, professionals and healthcare systems. The range describes its pharmaceutical activity without establishing each area’s share of sales.

Richmond · therapeutic areasConsulted

In-house development, licensing and technology

The portfolio combines generics, biosimilars, licences and technology transfers. Richmond also describes formulations combining active ingredients in one tablet. Its business therefore involves development and technology agreements alongside manufacturing; each product requires its own commercial and regulatory assessment.

Richmond · development and portfolioConsulted

Provider company profileSources consulted Text & translation: La Plata · AI assisted

Financials

Revenue and expenses, assets and liabilities, cash coming in and going out. Choose a statement and the period you want to explore.

Income statement

Income statement

Fiscal year 2025Period end:

ARS
Revenue
≈ 126.73B ARS126,725,752,789 ARS
Net revenue
—
Gross profit
≈ 69.86B ARS69,858,970,872 ARS
Operating income
≈ 30.29B ARS30,293,309,915 ARS
EBITDA
≈ 40.86B ARS40,860,816,600 ARS
EBIT
—
Net income
≈ 2.4B ARS2,404,122,353 ARS
Diluted EPS
≈ 29.77 ARS29.7719 ARS

Figures for the stated period. “—” means no data is available.

Each column is a fiscal year. “—” means no data is available.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Income statement · ARS
Indicator20252024202320222021202020192018
Revenue≈ 126.73B126,725,752,789≈ 120.75B120,754,054,143≈ 39.03B39,028,292,259≈ 18.47B18,470,278,525≈ 16.62B16,615,676,272≈ 6.18B6,181,338,494≈ 3.9B3,895,114,609≈ 1.82B1,816,998,248
Gross profit≈ 69.86B69,858,970,872≈ 65.8B65,802,441,693≈ 19.04B19,041,561,064≈ 8.23B8,234,291,800.000001≈ 4.65B4,651,824,832≈ 2.9B2,895,890,633≈ 1.8B1,799,252,824≈ 779.17M779,166,173
EBITDA≈ 40.86B40,860,816,600≈ 30.84B30,843,377,550≈ 7.68B7,684,626,570≈ 3.74B3,735,648,670≈ 2.67B2,668,135,390≈ 1.66B1,656,246,350≈ 917.52M917,522,480≈ 163.99M163,990,240
Net income≈ 2.4B2,404,122,353≈ 31.37B31,367,917,966≈ -10.85B-10,850,907,920≈ 163.43M163,432,199≈ 591.46M591,464,060≈ 486.24M486,240,523≈ 116.44M116,441,831≈ -215.6M-215,604,491
Basic EPSARS · per share≈ 29.7729.7719388.45≈ -134.37-134.3741≈ 2.022.0239≈ 7.327.3245≈ 6.026.0214≈ 1.441.442-2.67
Diluted EPSARS · per share≈ 29.7729.7719388.45≈ -134.37-134.3741≈ 2.022.0239≈ 7.327.3245≈ 6.026.0214≈ 1.441.442-2.67

Income statement

Income statement

Quarter 2 · fiscal 2026Period end:

ARS
Revenue
≈ 32.8B ARS32,798,047,513.999996 ARS
Net revenue
—
Gross profit
≈ 16.69B ARS16,686,832,080 ARS
Operating income
≈ 2.44B ARS2,444,878,123 ARS
EBITDA
≈ 7.19B ARS7,189,889,450 ARS
EBIT
—
Net income
≈ -8.65B ARS-8,652,189,147 ARS
Diluted EPS
≈ -107.15 ARS-107.1459 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Income statement

Income statement

Trailing 12 monthsPeriod-end date not specified

ARS
Revenue
≈ 131.24B ARS131,235,525,822 ARS
Net revenue
—
Gross profit
≈ 70.47B ARS70,472,688,371 ARS
Operating income
≈ 23.55B ARS23,550,096,807 ARS
EBITDA
≈ 37.15B ARS37,149,516,760 ARS
EBIT
≈ 23.55B ARS23,550,096,810 ARS
Net income
≈ 11.53B ARS11,525,949,791 ARS
Diluted EPS
≈ 142.73 ARS142.7336 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Balance sheet

Balance sheet

Fiscal year 2025Period end:

ARS
Total assets
≈ 421.39B ARS421,393,321,510 ARS
Total liabilities
≈ 328.35B ARS328,354,215,411 ARS
Total equity
≈ 93.04B ARS93,039,106,099 ARS
Total debt
≈ 246.38B ARS246,383,625,315 ARS
Cash & equivalents
≈ 10.85B ARS10,849,495,957 ARS
Cash & short-term investments
≈ 15.35B ARS15,348,834,565 ARS
Net debt
≈ 231.03B ARS231,034,790,750 ARS
Current assets
≈ 120.54B ARS120,537,744,589 ARS
Current liabilities
≈ 119.8B ARS119,795,422,930 ARS
Goodwill
≈ 5.69B ARS5,694,078,398 ARS

Figures for the stated period. “—” means no data is available.

Each column is a fiscal year. “—” means no data is available.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Balance sheet · ARS
Indicator20252024202320222021202020192018
Total assets≈ 421.39B421,393,321,510≈ 343.54B343,535,503,633≈ 155.79B155,786,002,381≈ 41B40,997,662,005≈ 25.76B25,759,803,215≈ 8.63B8,628,889,512≈ 5.19B5,185,205,940≈ 2.71B2,705,185,823
Total debt≈ 246.38B246,383,625,315≈ 188.92B188,919,880,179≈ 94.15B94,152,985,403≈ 21.45B21,450,480,026≈ 11.48B11,484,010,336≈ 1.73B1,729,084,929≈ 571.95M571,949,936≈ 422.23M422,227,742

Balance sheet

Balance sheet

Quarter 2 · fiscal 2026Period end:

ARS
Total assets
≈ 448.16B ARS448,156,770,393 ARS
Total liabilities
≈ 329.15B ARS329,145,447,236 ARS
Total equity
≈ 119.01B ARS119,011,323,157 ARS
Total debt
≈ 243.51B ARS243,507,411,651 ARS
Cash & equivalents
≈ 2.93B ARS2,926,226,641 ARS
Cash & short-term investments
≈ 3.87B ARS3,873,818,068 ARS
Net debt
≈ 239.63B ARS239,633,593,583 ARS
Current assets
≈ 99.32B ARS99,317,736,545 ARS
Current liabilities
≈ 107.55B ARS107,552,568,604 ARS
Goodwill
≈ 6.65B ARS6,653,298,658 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Cash flow

Cash flow

Fiscal year 2025Period end:

ARS
Operating cash flow
≈ 1.87B ARS1,866,133,687 ARS
Investing cash flow
≈ -51.03B ARS-51,028,919,847 ARS
Financing cash flow
≈ 54.55B ARS54,546,257,475 ARS
Capital expenditure · source sign
≈ -54.33B ARS-54,329,284,148 ARS
Free cash flow
≈ -35.92B ARS-35,920,964,940 ARS
Dividends paid · source sign
≈ -2.63B ARS-2,630,975,214 ARS

Figures for the stated period. “—” means no data is available.

Each column is a fiscal year. “—” means no data is available.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Cash flow · ARS
Indicator20252024202320222021202020192018
Free cash flow≈ -35.92B-35,920,964,940≈ 1.18B1,181,175,600≈ -11.91B-11,909,539,100≈ -10.97B-10,973,943,500≈ -1.56B-1,563,153,350≈ -480.46M-480,460,970≈ -189.25M-189,247,710≈ -276.92M-276,920,730

Cash flow

Cash flow

Quarter 2 · fiscal 2026Period end:

ARS
Operating cash flow
≈ 10.76B ARS10,761,332,525 ARS
Investing cash flow
≈ -4.24B ARS-4,241,799,025.9999995 ARS
Financing cash flow
≈ -7.02B ARS-7,019,825,281 ARS
Capital expenditure · source sign
≈ -4.13B ARS-4,128,119,506 ARS
Free cash flow
≈ 8.94B ARS8,938,321,060 ARS
Dividends paid · source sign
≈ -529.39M ARS-529,394,238 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Cash flow

Cash flow

Trailing 12 monthsPeriod-end date not specified

ARS
Operating cash flow
≈ 15.12B ARS15,116,996,465 ARS
Investing cash flow
≈ -27.47B ARS-27,466,152,991 ARS
Financing cash flow
≈ 9.41B ARS9,406,142,622 ARS
Capital expenditure · source sign
≈ -33.46B ARS-33,459,687,007 ARS
Free cash flow
≈ 732.24M ARS732,243,090 ARS
Dividends paid · source sign
≈ -858.43M ARS-858,430,415 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Short figures; ≈ indicates rounding.All available digits, without rounding.

Business performance

2018–2025 · ARS · Fiscal years

View performance

Annual results table

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

Revenue, Net income · ARS · 2018–2025
Fiscal yearRevenueNet income
2025126,725,752,7892,404,122,353
2024120,754,054,14331,367,917,966
202339,028,292,259-10,850,907,920
202218,470,278,525163,432,199
202116,615,676,272591,464,060
20206,181,338,494486,240,523
20193,895,114,609116,441,831
20181,816,998,248-215,604,491

Provider-reported annual values, newest first, without compacting numbers or filling missing periods. “—” means missing data, not zero.

Provider-reported historical figures may reflect different inflation adjustment bases. They are not recalculated or restated here.

Financial dataUpdated: Oct 03, 2026 · ARS

Valuation

P/E, forward P/E and other multiples relate equity or enterprise value to results and resources. Read them alongside profitability, debt and dividends, keeping reported figures distinct from estimates.

Valuation

Market capitalisation
≈ 121.93B ARS
Enterprise value · current
≈ 362.73B ARS
P/E · TTM
≈ 10.72×
Forward P/E
—
P/E · next FY · non-GAAP
—
P/B · latest quarter
≈ 1.05×
PEG · TTM
—
P/Free cash flow · TTM
≈ 168.73×
Forward P/B
—
P/S · TTM
≈ 0.941×
Forward P/S
—
EV/EBITDA · TTM
≈ 9.76×
Forward EV/EBITDA
—
EV/EBIT · TTM
≈ 15.4×
EV/Revenue · TTM
≈ 2.76×
P/Operating cash flow · TTM
≈ 8.17×
Earnings yield
≈ 9.33%

Multiples may use a price different from the BYMA close. Forward P/E and next-year non-GAAP P/E are separate series.

Financial dataUpdated: Oct 03, 2026 · ARS

Dividends

Dividends per share, payment dates and yield. Reported amounts and estimates are identified separately.

Dividends

Dividend yield · current
≈ 2.16%
Payout ratio · TTM
0%
Latest dividend per share
≈ 16.51 ARS
Ex-dividend date
Jun 12, 2026
Payment date
Jun 16, 2026
Estimated dividend per share · FY
—

Dividend-per-share history

View history
Financial dataUpdated: Oct 03, 2026 · ARS

Forecasts

Forecasts collect revenue and earnings estimates where available for this instrument. Check each figure’s forecast horizon and the publication history before comparing it with the company’s results.

Estimates, not reported results. NTM: next 12 months; next FY: following fiscal year. Individual estimate dates are unavailable.

Analyst estimates

EPS estimate · next 12 months
—
Revenue estimate · next 12 months
—
Net income estimate · next 12 months
—
EPS forecast · next FY
—
Revenue forecast · next FY
—
Average price target
—
Median price target
—
Lowest price target
—
Highest price target
—
Analysts with recommendations
—
Buy
—
Outperform
—
Hold
—
Underperform
—
Sell
—
Financial dataUpdated: Oct 03, 2026 · ARS

Shareholders

Ownership structure helps explain economic interests and control. Equity holdings and voting rights are shown separately, with the date and scope of verified information.

As of Sep 30, 2025 · Retrieved Sep 29, 2026

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Shareholders · %
Shareholder / groupCapitalVoting rights
Marcelo Rubén Figueiras38.54%—
Busnel S.A.24.74%—
Alberto Daniel Serventich15.24%—
Martín Eduardo Nadler3.94%—
Class B shareholders17.54%—

Capital ownership and voting rights are different measures. “—” means unavailable, not zero.

Roles reflect dated disclosures, not real-time confirmation. A directorship does not imply share ownership; holdings are shown separately.

RICH · Company metrics

What would you like to explore?

Explore the company, one topic at a time.

All metric groups

Filters & format

Period
Show

≈ indicates a rounded or abbreviated number. Enable “Exact values” to see all available digits.All available digits are shown without rounding. Downloads always retain the original values.

View results

Periods and units are identified when confirmed.

All metric groups

Valuation

Valuation
Market capitalisation≈ 121.93B ARS121,934,745,142 ARSPeriod not specified
Price / earnings (P/E)≈ 10.72×10.719270024717376×Last 12 months
Price / book value (P/B)≈ 1.05×1.0483942700853994×Quarter

How to read this group

Compare multiples on the same currency and period basis. P/E uses earnings; forward P/E uses estimates.

Definitions in the guide
RICH · Valuation
IndicatorIndicator and periodPeriodValue
Market capitalisationPeriod not specifiedPeriod not specified≈ 121.93B ARS121,934,745,142 ARS
Enterprise value (EV)Latest available figureLatest available figure≈ 362.73B ARS362,732,990,644 ARS
Enterprise value (EV)QuarterQuarter≈ 367.58B ARS367,578,080,092 ARS
Price / earnings (P/E)Latest available figureLatest available figure≈ 9.88×9.878542963955228×
Price / earnings (P/E)Last 12 monthsLast 12 months≈ 10.72×10.719270024717376×
Price / book value (P/B)Latest available figureLatest available figure≈ 0.966×0.9661672685100741×
Price / book value (P/B)QuarterQuarter≈ 1.05×1.0483942700853994×
Price / sales (P/S)Latest available figureLatest available figure≈ 0.868×0.8675973670759878×
Price / sales (P/S)Reported figure 1Period not specifiedPeriod not specified≈ 0.171×0.17104507586623305×
EV / EBITDALatest available figureLatest available figure≈ 9.76×9.764137525324838×
EV / EBITDALast 12 monthsLast 12 months≈ 9.76×9.764137525324838×
Earnings yieldPeriod not specifiedPeriod not specified≈ 9.33%9.328993464052287%
EV / free cash flowLast 12 monthsLast 12 months≈ 495.37×495.3723641748535×
EV / gross profitLast 12 monthsLast 12 months≈ 5.15×5.147142801398608×
EV/EBIT · TTMLast 12 monthsLast 12 months≈ 15.4×15.4026114444665×
EV/Revenue · TTMLast 12 monthsLast 12 months≈ 2.76×2.7639847394370127×
Graham numberLast 12 monthsLast 12 months≈ 2,164.9 ARS2,164.899623652972 ARS
Graham numberFinancial yearFinancial year≈ 871.2 ARS871.2008807769308 ARS
P/B · annual basisPeriod not specifiedPeriod not specified≈ 1.24×1.2444331474626802×
P/Operating cash flow · TTMLast 12 monthsLast 12 months≈ 8.17×8.172904941537274×
P/S · annual basisPeriod not specifiedPeriod not specified≈ 0.898×0.8984724427684245×
P/S · TTMLast 12 monthsLast 12 months≈ 0.941×0.9414354408696889×
Price / book value (P/B)Period not specifiedPeriod not specified≈ 1.35×1.3503423515020572×
Price / cashPeriod not specifiedPeriod not specified≈ 31.89×31.89354093074048×
Price / cash flowLatest available figureLatest available figure≈ 7.53×7.5318927892598255×
Price / free cash flowLatest available figureLatest available figure≈ 155.49×155.49425897620964×
Price / free cash flowLast 12 monthsLast 12 months≈ 168.73×168.72781293163177×
Price / sales (P/S)Reported figure 2Period not specifiedPeriod not specified≈ 0.975×0.9749381825785033×
Tobin’s Q · approximationFinancial yearFinancial year≈ 0.378×0.3784687100723672×
Tobin’s Q · approximationQuarterQuarter≈ 0.283×0.2828917088072184×

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Revenue & earnings

Revenue & earnings
Revenue≈ 126.73B ARS126,725,752,789 ARSFiscal year 2025Period end:
Operating income≈ 30.29B ARS30,293,309,915 ARSFiscal year 2025Period end:
Net income≈ 2.4B ARS2,404,122,353 ARSFiscal year 2025Period end:

How to read this group

Revenue, profit and cash generation describe different things. Read them alongside margins and operating cash flow.

Definitions in the guide
RICH · Revenue & earnings
IndicatorIndicator and periodPeriodValue
RevenueLast 12 monthsLast 12 months≈ 131.24B ARS131,235,525,822 ARS
RevenueFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 126.73B ARS126,725,752,789 ARS
RevenueQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 32.8B ARS32,798,047,513.999996 ARS
RevenueHalf-yearHalf-year≈ 61.54B ARS61,542,290,116 ARS
RevenuePeriod not specifiedPeriod not specified≈ 126.73B ARS126,725,752,789 ARS
Gross profitLast 12 monthsLast 12 months≈ 70.47B ARS70,472,688,371 ARS
Gross profitFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 69.86B ARS69,858,970,872 ARS
Gross profitQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 16.69B ARS16,686,832,080 ARS
Gross profitHalf-yearHalf-year≈ 29.99B ARS29,994,888,244 ARS
Gross profitPeriod not specifiedPeriod not specified≈ 69.86B ARS69,858,970,872 ARS
Operating incomeLast 12 monthsLast 12 months≈ 23.55B ARS23,550,096,807 ARS
Operating incomeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 30.29B ARS30,293,309,915 ARS
Operating incomeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.44B ARS2,444,878,123 ARS
Operating incomeHalf-yearHalf-year≈ 3.36B ARS3,358,438,467 ARS
EBITDALast 12 monthsLast 12 months≈ 37.15B ARS37,149,516,760 ARS
EBITDAFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 40.86B ARS40,860,816,600 ARS
EBITDAQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 7.19B ARS7,189,889,450 ARS
EBITDAHalf-yearHalf-year≈ 11.27B ARS11,273,984,180 ARS
EBITDAPeriod not specifiedPeriod not specified≈ 37.15B ARS37,149,516,760 ARS
EBITLast 12 monthsLast 12 months≈ 23.55B ARS23,550,096,810 ARS
Net incomeLast 12 monthsLast 12 months≈ 11.53B ARS11,525,949,791 ARS
Net incomeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 2.4B ARS2,404,122,353 ARS
Net incomeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -8.65B ARS-8,652,189,147 ARS
Net incomeHalf-yearHalf-year≈ 12.51B ARS12,506,766,726 ARS
Net incomePeriod not specifiedPeriod not specified≈ 2.4B ARS2,404,122,353 ARS
Basic EPSLast 12 monthsLast 12 months≈ 142.73 ARS142.7336 ARS
Basic EPSFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 29.77 ARS29.7719 ARS
Basic EPSQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -107.15 ARS-107.1459 ARS
Basic EPSHalf-yearHalf-year≈ 154.88 ARS154.8797 ARS
Diluted EPSLast 12 monthsLast 12 months≈ 142.73 ARS142.7336 ARS
Diluted EPSFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 29.77 ARS29.7719 ARS
Diluted EPSQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -107.15 ARS-107.1459 ARS
Diluted EPSHalf-yearHalf-year≈ 154.88 ARS154.8797 ARS
EBIT per shareLatest available figureLatest available figure≈ 291.64 ARS291.6366953094003 ARS
EBIT per shareLast 12 monthsLast 12 months≈ 291.64 ARS291.6366953094003 ARS
EBIT per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 375.14 ARS375.142440658709 ARS
EBIT per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 30.28 ARS30.2765708822179 ARS
EBITDA per shareLatest available figureLatest available figure≈ 460.05 ARS460.0474633984139 ARS
EBITDA per shareLast 12 monthsLast 12 months≈ 460.05 ARS460.0474633984139 ARS
EBITDA per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 506.01 ARS506.00698659580104 ARS
EBITDA per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 89.04 ARS89.03723902941874 ARS
Net income before discontinued operationsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 2.4B ARS2,404,122,353 ARS
Revenue per shareLatest available figureLatest available figure≈ 1,625.18 ARS1,625.17782269446 ARS
Revenue per shareLast 12 monthsLast 12 months≈ 1,625.18 ARS1,625.17782269446 ARS
Revenue per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1,569.33 ARS1,569.33026866737 ARS
Revenue per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 406.16 ARS406.160291686022 ARS

Choose an indicator to explore its history.

Financial year

Basic EPS

Earnings attributable to each ordinary share, using the average share count for the period. It is not the dividend.

Revenue & earnings

RevenueLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Revenue · ARS
Position in seriesValue · ARS
1≈ 131.24B ARS131,235,525,822 ARS
2≈ 123.62B ARS123,615,462,296 ARS
3≈ 121.89B ARS121,889,126,941 ARS
4≈ 117.03B ARS117,027,506,360 ARS
5≈ 105.86B ARS105,861,276,051 ARS
6≈ 97.64B ARS97,642,400,472 ARS
7≈ 85B ARS85,000,119,329 ARS
8≈ 70.88B ARS70,876,195,899 ARS
Revenue & earnings

RevenueFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Revenue
RevenueARS
2025≈ 126.73B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Revenue · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 126.73B ARS126,725,752,789 ARS
2024≈ 120.75B ARS120,754,054,143 ARS
2023≈ 39.03B ARS39,028,292,259 ARS
2022≈ 18.47B ARS18,470,278,525 ARS
2021≈ 16.62B ARS16,615,676,272 ARS
2020≈ 6.18B ARS6,181,338,494 ARS
2019≈ 3.9B ARS3,895,114,609 ARS
2018≈ 1.82B ARS1,816,998,248 ARS
Revenue & earnings

RevenueQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Revenue · ARS
Position in seriesValue · ARS
1≈ 32.8B ARS32,798,047,513.999996 ARS
2≈ 28.74B ARS28,744,242,602 ARS
3≈ 38.82B ARS38,815,589,269 ARS
4≈ 30.88B ARS30,877,646,437 ARS
5≈ 25.18B ARS25,177,983,988 ARS
6≈ 27.02B ARS27,017,907,247 ARS
7≈ 33.95B ARS33,953,968,688 ARS
8≈ 19.71B ARS19,711,416,128 ARS
9≈ 16.96B ARS16,959,108,409 ARS
10≈ 14.38B ARS14,375,626,104 ARS
11≈ 19.83B ARS19,830,045,258 ARS
12≈ 5.61B ARS5,608,575,021 ARS
13≈ 4.49B ARS4,489,329,409 ARS
14≈ 4.52B ARS4,516,387,613 ARS
15≈ 6.21B ARS6,212,792,264 ARS
16≈ 2.77B ARS2,774,599,888 ARS
17≈ 4.91B ARS4,908,136,115 ARS
18≈ 2.44B ARS2,443,452,668 ARS
19≈ 7.99B ARS7,985,437,388 ARS
20≈ 4.98B ARS4,978,945,724 ARS
21≈ 1.28B ARS1,275,595,531 ARS
22≈ 1.34B ARS1,335,935,510 ARS
23≈ 1.01B ARS1,009,681,148 ARS
24≈ 985.59M ARS985,590,487 ARS
25≈ 977.4M ARS977,404,753 ARS
26≈ 591.18M ARS591,181,464 ARS
27≈ 462.41M ARS462,408,974 ARS
28≈ 253.05M ARS253,045,198 ARS
29≈ 241.71M ARS241,713,911 ARS
30≈ 192.33M ARS192,331,245 ARS
31≈ 136.21M ARS136,205,206 ARS
Revenue & earnings

Gross profitLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Gross profit · ARS
Position in seriesValue · ARS
1≈ 70.47B ARS70,472,688,371 ARS
2≈ 68.61B ARS68,605,383,019.99999 ARS
3≈ 68B ARS68,002,346,913.99999 ARS
4≈ 62.09B ARS62,092,760,876 ARS
5≈ 54.53B ARS54,533,538,072 ARS
6≈ 47.63B ARS47,633,353,140 ARS
7≈ 41.66B ARS41,657,121,316 ARS
8≈ 36.4B ARS36,401,853,071 ARS
Revenue & earnings

Gross profitFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Gross profit
Gross profitARS
2025≈ 69.86B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Gross profit · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 69.86B ARS69,858,970,872 ARS
2024≈ 65.8B ARS65,802,441,693 ARS
2023≈ 19.04B ARS19,041,561,064 ARS
2022≈ 8.23B ARS8,234,291,800.000001 ARS
2021≈ 4.65B ARS4,651,824,832 ARS
2020≈ 2.9B ARS2,895,890,633 ARS
2019≈ 1.8B ARS1,799,252,824 ARS
2018≈ 779.17M ARS779,166,173 ARS
Revenue & earnings

Gross profitQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Gross profit · ARS
Position in seriesValue · ARS
1≈ 16.69B ARS16,686,832,080 ARS
2≈ 13.31B ARS13,308,056,164 ARS
3≈ 22.79B ARS22,788,039,118 ARS
4≈ 17.69B ARS17,689,761,009 ARS
5≈ 14.82B ARS14,819,526,729 ARS
6≈ 12.71B ARS12,705,020,058 ARS
7≈ 16.88B ARS16,878,453,080 ARS
8≈ 10.13B ARS10,130,538,205 ARS
9≈ 7.92B ARS7,919,341,797 ARS
10≈ 6.73B ARS6,728,788,234 ARS
11≈ 11.62B ARS11,623,184,835 ARS
12≈ 1.37B ARS1,372,421,871 ARS
13≈ 2.03B ARS2,026,535,625 ARS
14≈ 1.99B ARS1,985,669,787 ARS
15≈ 3.53B ARS3,529,714,836 ARS
16≈ 1.13B ARS1,131,885,930 ARS
17≈ 1.59B ARS1,586,100,747 ARS
18≈ 1.14B ARS1,144,821,704 ARS
19≈ 2.11B ARS2,112,755,070.0000002 ARS
20≈ 774.48M ARS774,478,261 ARS
21≈ 637.42M ARS637,417,928 ARS
22≈ 684.18M ARS684,177,296 ARS
23≈ 516.36M ARS516,357,082 ARS
24≈ 463.08M ARS463,077,533 ARS
25≈ 517.63M ARS517,627,995.00000006 ARS
26≈ 263.5M ARS263,503,626 ARS
27≈ 162.55M ARS162,551,760 ARS
28≈ 134.31M ARS134,309,975 ARS
29≈ 122.77M ARS122,771,647 ARS
30≈ 103.38M ARS103,381,136 ARS
31≈ 79.12M ARS79,121,822 ARS
Revenue & earnings

EBITDALast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · EBITDA · ARS
Position in seriesValue · ARS
1≈ 37.15B ARS37,149,516,760 ARS
2≈ 36.98B ARS36,982,621,660 ARS
3≈ 39.61B ARS39,613,452,470 ARS
4≈ 34.82B ARS34,815,570,810 ARS
5≈ 29.85B ARS29,854,628,770 ARS
6≈ 26.06B ARS26,059,168,300 ARS
7≈ 22.03B ARS22,032,745,610 ARS
8≈ 17.36B ARS17,356,303,260 ARS
Revenue & earnings

EBITDAFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

EBITDA
EBITDAARS
2025≈ 40.86B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · EBITDA · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 40.86B ARS40,860,816,600 ARS
2024≈ 30.84B ARS30,843,377,550 ARS
2023≈ 7.68B ARS7,684,626,570 ARS
2022≈ 3.74B ARS3,735,648,670 ARS
2021≈ 2.67B ARS2,668,135,390 ARS
2020≈ 1.66B ARS1,656,246,350 ARS
2019≈ 917.52M ARS917,522,480 ARS
2018≈ 163.99M ARS163,990,240 ARS
Revenue & earnings

EBITDAQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · EBITDA · ARS
Position in seriesValue · ARS
1≈ 7.19B ARS7,189,889,450 ARS
2≈ 4.08B ARS4,084,094,730 ARS
3≈ 15.84B ARS15,840,144,770 ARS
4≈ 10.04B ARS10,035,387,800 ARS
5≈ 7.02B ARS7,022,994,360 ARS
6≈ 6.71B ARS6,714,925,540 ARS
7≈ 11.04B ARS11,042,263,130 ARS
8≈ 5.07B ARS5,074,445,770 ARS
9≈ 3.23B ARS3,227,533,880 ARS
10≈ 2.69B ARS2,688,502,850 ARS
11≈ 6.37B ARS6,365,820,780 ARS
12≈ -551.82M ARS-551,815,110 ARS
13≈ 348.49M ARS348,494,700 ARS
14≈ 839.37M ARS839,374,620 ARS
15≈ 1.78B ARS1,777,138,270 ARS
16≈ 239.18M ARS239,175,490 ARS
17≈ 802.09M ARS802,091,420 ARS
18≈ 513.77M ARS513,770,000 ARS
19≈ 1.45B ARS1,446,806,930 ARS
20≈ 286.96M ARS286,964,560 ARS
21≈ 264.9M ARS264,895,350 ARS
22≈ 417.16M ARS417,159,740 ARS
23≈ 243.08M ARS243,076,120 ARS
24≈ 203.72M ARS203,723,440 ARS
25≈ 314.25M ARS314,252,910 ARS
26≈ 65.86M ARS65,862,290 ARS
27≈ 3.27M ARS3,265,680 ARS
28≈ 50.43M ARS50,432,090 ARS
29≈ 40.29M ARS40,286,000 ARS
30≈ 24.19M ARS24,192,950 ARS
31≈ 36.17M ARS36,165,620 ARS
Revenue & earnings

Net incomeLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Net income · ARS
Position in seriesValue · ARS
1≈ 11.53B ARS11,525,949,791 ARS
2≈ 17.37B ARS17,366,719,083 ARS
3≈ 1.87B ARS1,872,858,171 ARS
4≈ -484.93M ARS-484,932,470.000001 ARS
5≈ 14.24B ARS14,238,200,710 ARS
6≈ 20.01B ARS20,008,126,070 ARS
7≈ 21.22B ARS21,220,194,672 ARS
8≈ 7.78B ARS7,775,179,987 ARS
Revenue & earnings

Net incomeFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Net income
Net incomeARS
2025≈ 2.4B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Net income · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 2.4B ARS2,404,122,353 ARS
2024≈ 31.37B ARS31,367,917,966 ARS
2023≈ -10.85B ARS-10,850,907,920 ARS
2022≈ 163.43M ARS163,432,199 ARS
2021≈ 591.46M ARS591,464,060 ARS
2020≈ 486.24M ARS486,240,523 ARS
2019≈ 116.44M ARS116,441,831 ARS
2018≈ -215.6M ARS-215,604,491 ARS
Revenue & earnings

Net incomeQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Net income · ARS
Position in seriesValue · ARS
1≈ -8.65B ARS-8,652,189,147 ARS
2≈ 21.16B ARS21,158,955,873 ARS
3≈ 8.19B ARS8,190,005,894 ARS
4≈ -9.17B ARS-9,170,822,829 ARS
5≈ -2.81B ARS-2,811,419,855 ARS
6≈ 5.67B ARS5,665,094,961 ARS
7≈ 5.83B ARS5,832,215,253 ARS
8≈ 5.55B ARS5,552,310,351 ARS
9≈ 2.96B ARS2,958,505,505 ARS
10≈ 6.88B ARS6,877,163,563 ARS
11≈ -7.61B ARS-7,612,799,432 ARS
12≈ -2.04B ARS-2,044,087,485 ARS
13≈ -978.1M ARS-978,098,610 ARS
14≈ 74.7M ARS74,702,489 ARS
15≈ -554.43M ARS-554,432,526 ARS
16≈ -173.61M ARS-173,608,016 ARS
17≈ 468.26M ARS468,258,139 ARS
18≈ 223.86M ARS223,864,876 ARS
19≈ 696.66M ARS696,655,430 ARS
20≈ -77.58M ARS-77,581,610 ARS
21≈ -99.27M ARS-99,273,850 ARS
22≈ 133.04M ARS133,044,091.00000001 ARS
23≈ 49.67M ARS49,674,940 ARS
24≈ -19.13M ARS-19,126,718 ARS
25≈ 26.17M ARS26,167,185 ARS
26≈ 1.94M ARS1,944,408 ARS
27≈ -68.41M ARS-68,410,593 ARS
28≈ 17.65M ARS17,650,915 ARS
29≈ 2.38M ARS2,379,167 ARS
30≈ 10.63M ARS10,630,118 ARS
31-144,878 ARS
Revenue & earnings

Basic EPSFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Basic EPS
Basic EPSARS
2025≈ 29.77 ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Basic EPS · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 29.77 ARS29.7719 ARS
2024388.45 ARS
2023≈ -134.37 ARS-134.3741 ARS
2022≈ 2.02 ARS2.0239 ARS
2021≈ 7.32 ARS7.3245 ARS
2020≈ 6.02 ARS6.0214 ARS
2019≈ 1.44 ARS1.442 ARS
2018-2.67 ARS
Revenue & earnings

Diluted EPSLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Diluted EPS · ARS
Position in seriesValue · ARS
1≈ 142.73 ARS142.7336 ARS
2≈ 215.06 ARS215.0638 ARS
3≈ 23.19 ARS23.1929 ARS
4≈ -6.01 ARS-6.0052 ARS
5≈ 176.32 ARS176.3212 ARS
6≈ 247.77 ARS247.7741 ARS
7≈ 262.78 ARS262.784 ARS
8≈ 96.29 ARS96.2853 ARS
Revenue & earnings

Diluted EPSFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Diluted EPS
Diluted EPSARS
2025≈ 29.77 ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Diluted EPS · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 29.77 ARS29.7719 ARS
2024388.45 ARS
2023≈ -134.37 ARS-134.3741 ARS
2022≈ 2.02 ARS2.0239 ARS
2021≈ 7.32 ARS7.3245 ARS
2020≈ 6.02 ARS6.0214 ARS
2019≈ 1.44 ARS1.442 ARS
2018-2.67 ARS
Revenue & earnings

Diluted EPSQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Diluted EPS · ARS
Position in seriesValue · ARS
1≈ -107.15 ARS-107.1459 ARS
2≈ 262.03 ARS262.0256 ARS
3≈ 101.42 ARS101.4223 ARS
4≈ -113.57 ARS-113.5685 ARS
5≈ -34.82 ARS-34.8157 ARS
6≈ 70.15 ARS70.1547 ARS
7≈ 72.22 ARS72.2242 ARS
8≈ 68.76 ARS68.758 ARS
9≈ 36.64 ARS36.6372 ARS
10≈ 85.16 ARS85.1645 ARS
11≈ -94.27 ARS-94.2744 ARS
12≈ -25.31 ARS-25.3133 ARS
13≈ -12.11 ARS-12.1125 ARS
14≈ 0.925 ARS0.9251 ARS
15≈ -6.87 ARS-6.8659 ARS
16≈ -2.15 ARS-2.1499 ARS
17≈ 5.8 ARS5.7988 ARS
18≈ 2.77 ARS2.7723 ARS
19≈ 8.63 ARS8.6272 ARS
20≈ -0.961 ARS-0.9608 ARS
21≈ -1.23 ARS-1.2294 ARS
22≈ 1.65 ARS1.6476 ARS
23≈ 0.615 ARS0.6152 ARS
24≈ -0.237 ARS-0.2369 ARS
250.324 ARS
260.0241 ARS
27≈ -0.847 ARS-0.8472 ARS
28≈ 0.265 ARS0.2651 ARS
290.0357 ARS
30≈ 0.16 ARS0.1596 ARS
31-0.0022 ARS
All metric groups

Balance sheet

Balance sheet
Total assets≈ 421.39B ARS421,393,321,510 ARSFiscal year 2025Period end:
Total liabilities≈ 328.35B ARS328,354,215,411 ARSFiscal year 2025Period end:
Total equity≈ 93.04B ARS93,039,106,099 ARSFiscal year 2025Period end:

How to read this group

The balance sheet describes one date. Read assets, liabilities and equity together; debt and total liabilities differ.

Definitions in the guide
RICH · Balance sheet
IndicatorIndicator and periodPeriodValue
Total assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 421.39B ARS421,393,321,510 ARS
Total assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 448.16B ARS448,156,770,393 ARS
Total assetsPeriod not specifiedPeriod not specified≈ 448.16B ARS448,156,770,393 ARS
Current assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 120.54B ARS120,537,744,589 ARS
Current assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 99.32B ARS99,317,736,545 ARS
Current assetsPeriod not specifiedPeriod not specified≈ 99.32B ARS99,317,736,545 ARS
Total liabilitiesFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 328.35B ARS328,354,215,411 ARS
Total liabilitiesQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 329.15B ARS329,145,447,236 ARS
Current liabilitiesFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 119.8B ARS119,795,422,930 ARS
Current liabilitiesQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 107.55B ARS107,552,568,604 ARS
Total equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 93.04B ARS93,039,106,099 ARS
Total equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 119.01B ARS119,011,323,157 ARS
Total debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 246.38B ARS246,383,625,315 ARS
Total debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 243.51B ARS243,507,411,651 ARS
Total debtPeriod not specifiedPeriod not specified≈ 243.51B ARS243,507,411,651 ARS
Net debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 231.03B ARS231,034,790,750 ARS
Net debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 239.63B ARS239,633,593,583 ARS
Net debtPeriod not specifiedPeriod not specified≈ 239.63B ARS239,633,593,583 ARS
Book value per shareLatest available figureLatest available figure≈ 1,459.37 ARS1,459.37463 ARS
Book value per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1,133.05 ARS1,133.046 ARS
Book value per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 1,459.37 ARS1,459.37463 ARS
Cash & equivalentsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 10.85B ARS10,849,495,957 ARS
Cash & equivalentsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.93B ARS2,926,226,641 ARS
Cash & short-term investmentsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 15.35B ARS15,348,834,565 ARS
Cash & short-term investmentsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.87B ARS3,873,818,068 ARS
Cash per shareLatest available figureLatest available figure≈ 47.97 ARS47.97209577081844 ARS
Cash per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 190.07 ARS190.07494642172966 ARS
Cash per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 47.97 ARS47.97209577081844 ARS
GoodwillFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 5.69B ARS5,694,078,398 ARS
GoodwillQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 6.65B ARS6,653,298,658 ARS
GoodwillPeriod not specifiedPeriod not specified≈ 6.65B ARS6,653,298,658 ARS
Long-term debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 186.58B ARS186,579,540,470 ARS
Long-term debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 195.15B ARS195,153,780,481 ARS
Shareholders’ equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 91.5B ARS91,495,149,463 ARS
Shareholders’ equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 117.85B ARS117,846,671,238 ARS
Short-term debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 59.8B ARS59,804,084,845 ARS
Short-term debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 48.35B ARS48,353,631,170 ARS
Tangible book value per shareLatest available figureLatest available figure≈ 753.04 ARS753.040808945103 ARS
Tangible book value per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 543 ARS543.002017510835 ARS
Tangible book value per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 753.04 ARS753.040808945103 ARS
Total debt per shareLatest available figureLatest available figure≈ 3,015.52 ARS3,015.5161310032595 ARS
Total debt per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 3,051.13 ARS3,051.1342201661255 ARS
Total debt per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3,015.52 ARS3,015.5161310032595 ARS
Working capitalQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -8.23B ARS-8,234,832,058.9999895 ARS
Working capital per shareLatest available figureLatest available figure≈ -101.98 ARS-101.977466483063 ARS
Working capital per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 9.19 ARS9.1926686006413 ARS
Working capital per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -101.98 ARS-101.977466483063 ARS

Choose an indicator to explore its history.

Total assets

Resources recorded on the balance sheet: cash, property and rights. Their accounting amount is not the company’s stock-market value.

Total debt

Borrowed financing the company must repay. It is part of liabilities, not every obligation of the business.

Balance sheet

Total assetsFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Total assets
Total assetsARS
2025≈ 421.39B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Total assets · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 421.39B ARS421,393,321,510 ARS
2024≈ 343.54B ARS343,535,503,633 ARS
2023≈ 155.79B ARS155,786,002,381 ARS
2022≈ 41B ARS40,997,662,005 ARS
2021≈ 25.76B ARS25,759,803,215 ARS
2020≈ 8.63B ARS8,628,889,512 ARS
2019≈ 5.19B ARS5,185,205,940 ARS
2018≈ 2.71B ARS2,705,185,823 ARS
Balance sheet

Total assetsQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Total assets · ARS
Position in seriesValue · ARS
1≈ 448.16B ARS448,156,770,393 ARS
2≈ 437.69B ARS437,689,841,213 ARS
3≈ 421.39B ARS421,393,321,510 ARS
4≈ 355.78B ARS355,780,864,244 ARS
5≈ 322.88B ARS322,884,487,665 ARS
6≈ 296.1B ARS296,097,538,892 ARS
7≈ 261.15B ARS261,146,895,107 ARS
8≈ 249.42B ARS249,416,094,218 ARS
9≈ 212.71B ARS212,707,609,635 ARS
10≈ 190.4B ARS190,399,741,742 ARS
11≈ 155.79B ARS155,786,002,381 ARS
12≈ 79.12B ARS79,122,269,050 ARS
13≈ 59.42B ARS59,423,600,522 ARS
14≈ 47.92B ARS47,917,935,133 ARS
15≈ 41B ARS40,997,662,005 ARS
16≈ 33.6B ARS33,604,316,841 ARS
17≈ 31.01B ARS31,012,605,836 ARS
18≈ 26.14B ARS26,142,549,578 ARS
19≈ 25.76B ARS25,759,803,215 ARS
20≈ 24.24B ARS24,239,296,682 ARS
21≈ 9.32B ARS9,320,900,889 ARS
22≈ 7.03B ARS7,032,986,005 ARS
23≈ 5.89B ARS5,890,785,166 ARS
24≈ 5.31B ARS5,314,744,791 ARS
25≈ 3.82B ARS3,821,942,797 ARS
26≈ 2.96B ARS2,960,904,368 ARS
27≈ 2.83B ARS2,831,150,598 ARS
28≈ 912.39M ARS912,390,458 ARS
29≈ 779.15M ARS779,149,394 ARS
30≈ 726.25M ARS726,252,833 ARS
31≈ 556.55M ARS556,554,579 ARS
Balance sheet

Total debtFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Total debt
Total debtARS
2025≈ 246.38B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Total debt · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 246.38B ARS246,383,625,315 ARS
2024≈ 188.92B ARS188,919,880,179 ARS
2023≈ 94.15B ARS94,152,985,403 ARS
2022≈ 21.45B ARS21,450,480,026 ARS
2021≈ 11.48B ARS11,484,010,336 ARS
2020≈ 1.73B ARS1,729,084,929 ARS
2019≈ 571.95M ARS571,949,936 ARS
2018≈ 422.23M ARS422,227,742 ARS
Balance sheet

Total debtQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Total debt · ARS
Position in seriesValue · ARS
1≈ 243.51B ARS243,507,411,651 ARS
2≈ 235.79B ARS235,786,239,196 ARS
3≈ 246.38B ARS246,383,625,315 ARS
4≈ 213.33B ARS213,325,466,509 ARS
5≈ 188.08B ARS188,081,382,327 ARS
6≈ 165.48B ARS165,482,961,769 ARS
7≈ 143.61B ARS143,612,056,429 ARS
8≈ 136.78B ARS136,783,449,887 ARS
9≈ 110.75B ARS110,753,782,525 ARS
10≈ 103.04B ARS103,040,166,540 ARS
11≈ 94.15B ARS94,152,985,403 ARS
12≈ 42.35B ARS42,348,604,343 ARS
13≈ 31.59B ARS31,588,347,449 ARS
14≈ 25.07B ARS25,069,963,531 ARS
15≈ 21.45B ARS21,450,480,026 ARS
16≈ 16.25B ARS16,251,816,634 ARS
17≈ 14B ARS13,998,120,819 ARS
18≈ 12.23B ARS12,226,725,712 ARS
19≈ 11.48B ARS11,484,010,336 ARS
20≈ 10.84B ARS10,843,781,890 ARS
21≈ 1.75B ARS1,750,799,731 ARS
22≈ 1.31B ARS1,309,209,710 ARS
23≈ 804.98M ARS804,978,122 ARS
24≈ 548.53M ARS548,533,986 ARS
25≈ 552.05M ARS552,054,246 ARS
26≈ 442.5M ARS442,501,476 ARS
27≈ 453.88M ARS453,881,160 ARS
28≈ 226.33M ARS226,327,433 ARS
29≈ 176.51M ARS176,510,657 ARS
30≈ 187.27M ARS187,267,876 ARS
31≈ 151.65M ARS151,647,311 ARS
All metric groups

Cash flow

Cash flow
Operating cash flow≈ 1.87B ARS1,866,133,687 ARSFiscal year 2025Period end:
Fixed-asset investment≈ -54.33B ARS-54,329,284,148 ARSFiscal year 2025Period end:
Free cash flow≈ -35.92B ARS-35,920,964,940 ARSFiscal year 2025Period end:

How to read this group

Free cash flow depends on its definition. We preserve the received amount and sign without recalculating it from other rows.

Definitions in the guide
RICH · Cash flow
IndicatorIndicator and periodPeriodValue
Operating cash flowLast 12 monthsLast 12 months≈ 15.12B ARS15,116,996,465 ARS
Operating cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.87B ARS1,866,133,687 ARS
Operating cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 10.76B ARS10,761,332,525 ARS
Operating cash flowHalf-yearHalf-year≈ 14.86B ARS14,859,472,334 ARS
Investing cash flowLast 12 monthsLast 12 months≈ -27.47B ARS-27,466,152,991 ARS
Investing cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -51.03B ARS-51,028,919,847 ARS
Investing cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -4.24B ARS-4,241,799,025.9999995 ARS
Investing cash flowHalf-yearHalf-year≈ -8.06B ARS-8,057,451,612 ARS
Financing cash flowLast 12 monthsLast 12 months≈ 9.41B ARS9,406,142,622 ARS
Financing cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 54.55B ARS54,546,257,475 ARS
Financing cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -7.02B ARS-7,019,825,281 ARS
Financing cash flowHalf-yearHalf-year≈ -20.86B ARS-20,862,690,601 ARS
Capital expenditure · source signLast 12 monthsLast 12 months≈ -33.46B ARS-33,459,687,007 ARS
Capital expenditure · source signFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -54.33B ARS-54,329,284,148 ARS
Capital expenditure · source signQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -4.13B ARS-4,128,119,506 ARS
Capital expenditure · source signHalf-yearHalf-year≈ -8.52B ARS-8,523,969,092 ARS
Free cash flowLast 12 monthsLast 12 months≈ 732.24M ARS732,243,090 ARS
Free cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -35.92B ARS-35,920,964,940 ARS
Free cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 8.94B ARS8,938,321,060 ARS
Free cash flowHalf-yearHalf-year≈ 11.78B ARS11,778,674,470 ARS
Free cash flowPeriod not specifiedPeriod not specified≈ 732.24M ARS732,243,090 ARS
Capital expenditure per shareLatest available figureLatest available figure≈ 414.35 ARS414.353818735251 ARS
Capital expenditure per shareLast 12 monthsLast 12 months≈ 414.35 ARS414.353818735251 ARS
Capital expenditure per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 672.8 ARS672.796082974918 ARS
Capital expenditure per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 51.12 ARS51.1212815932418 ARS
Free cash flow per shareLatest available figureLatest available figure≈ 9.07 ARS9.067858898994642 ARS
Free cash flow per shareLast 12 monthsLast 12 months≈ 9.07 ARS9.067858898994642 ARS
Free cash flow per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -444.83 ARS-444.83347953703935 ARS
Free cash flow per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 110.69 ARS110.68924414977027 ARS
Operating cash flow per shareLatest available figureLatest available figure≈ 187.2 ARS187.203939229008 ARS
Operating cash flow per shareLast 12 monthsLast 12 months≈ 187.2 ARS187.203939229008 ARS
Operating cash flow per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 23.11 ARS23.109589139826 ARS
Operating cash flow per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 133.26 ARS133.264821798266 ARS

Choose an indicator to explore its history.

Cash flow

Free cash flowLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Free cash flow · ARS
Position in seriesValue · ARS
1≈ 732.24M ARS732,243,090 ARS
2≈ -13.81B ARS-13,812,162,350 ARS
3≈ -35.92B ARS-35,920,964,940 ARS
4≈ -30.02B ARS-30,015,726,870 ARS
5≈ -22.51B ARS-22,508,617,210 ARS
6≈ -17.46B ARS-17,457,575,760 ARS
7≈ 897.9M ARS897,899,450 ARS
8≈ -7.18B ARS-7,182,735,270 ARS
Cash flow

Free cash flowFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Free cash flow
Free cash flowARS
2025≈ -35.92B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Free cash flow · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ -35.92B ARS-35,920,964,940 ARS
2024≈ 1.18B ARS1,181,175,600 ARS
2023≈ -11.91B ARS-11,909,539,100 ARS
2022≈ -10.97B ARS-10,973,943,500 ARS
2021≈ -1.56B ARS-1,563,153,350 ARS
2020≈ -480.46M ARS-480,460,970 ARS
2019≈ -189.25M ARS-189,247,710 ARS
2018≈ -276.92M ARS-276,920,730 ARS
Cash flow

Free cash flowQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Free cash flow · ARS
Position in seriesValue · ARS
1≈ 8.94B ARS8,938,321,060 ARS
2≈ 2.84B ARS2,840,353,410 ARS
3≈ -2.93B ARS-2,929,250,850 ARS
4≈ -8.12B ARS-8,117,180,530 ARS
5≈ -5.61B ARS-5,606,084,370 ARS
6≈ -19.27B ARS-19,268,449,180 ARS
7≈ 2.98B ARS2,975,987,220 ARS
8≈ -610.07M ARS-610,070,870 ARS
9≈ -555.04M ARS-555,042,920 ARS
10≈ -912.97M ARS-912,973,970 ARS
11≈ -5.1B ARS-5,104,647,500 ARS
12≈ -3.89B ARS-3,889,458,830 ARS
13≈ -2.06B ARS-2,056,036,300.0000002 ARS
14≈ -859.4M ARS-859,396,460 ARS
15≈ -2.95B ARS-2,946,295,170 ARS
16≈ -3.41B ARS-3,408,830,050 ARS
17≈ -1.08B ARS-1,082,106,970 ARS
18≈ -3.54B ARS-3,536,711,300 ARS
19≈ -2.29B ARS-2,285,373,680 ARS
20—
21≈ 276.02M ARS276,021,090 ARS
22≈ -612.95M ARS-612,947,530 ARS
23≈ 44.33M ARS44,326,910 ARS
24≈ 155.11M ARS155,109,020 ARS
25≈ 5.4M ARS5,402,310 ARS
26≈ -16.45M ARS-16,450,080 ARS
27≈ -119.52M ARS-119,522,920 ARS
28≈ -62.38M ARS-62,383,940 ARS
29≈ 42.11M ARS42,107,850 ARS
30≈ 71.86M ARS71,855,920 ARS
31≈ 14.39M ARS14,389,930 ARS
Cash flow

Capital expenditure · unspecified calculation basisLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

This series’ unit is not confirmed; values are shown without conversion.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Capital expenditure · unspecified calculation basis · unit not specified
Position in seriesValue · unit not specified
1≈ 33.46B33,459,687,007
2≈ 36.86B36,864,181,880
3≈ 54.33B54,329,284,148
4≈ 42.87B42,870,117,882
5≈ 34.62B34,621,212,227
6≈ 29.28B29,280,834,860
7≈ 8.81B8,809,632,964
8≈ 12.87B12,872,032,241
Cash flow

Capital expenditure · unspecified calculation basisFinancial year

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

This series’ unit is not confirmed; values are shown without conversion.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Capital expenditure · unspecified calculation basis · unit not specified
Position in seriesValue · unit not specified
1≈ 54.33B54,329,284,148
2≈ 11.59B11,588,962,970
3≈ 12.52B12,516,258,029
4≈ 7.52B7,519,213,383
5≈ 5.93B5,928,165,160
6≈ 638.08M638,075,063
7≈ 449.62M449,624,708
8≈ 253.14M253,139,170
Cash flow

Capital expenditure · unspecified calculation basisQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

This series’ unit is not confirmed; values are shown without conversion.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Capital expenditure · unspecified calculation basis · unit not specified
Position in seriesValue · unit not specified
1≈ 4.13B4,128,119,506
2≈ 4.4B4,395,849,586
3≈ 14.74B14,738,045,080
4≈ 10.2B10,197,672,835
5≈ 7.53B7,532,614,379
6≈ 21.86B21,860,951,854
7≈ 3.28B3,278,878,814
8≈ 1.95B1,948,767,180
9≈ 2.19B2,192,237,012
10≈ 1.39B1,389,749,958
11≈ 7.34B7,341,278,091
12≈ 2.37B2,365,856,525
13≈ 1.79B1,786,804,751
14≈ 1.02B1,022,318,662
15≈ 2.68B2,679,352,564
16≈ 1.33B1,325,244,307
17≈ 1.14B1,137,864,129
18≈ 2.38B2,376,752,383
19≈ 4.96B4,956,287,438
20—
21≈ 196.42M196,416,994
22≈ 51.83M51,834,978
23≈ 45.12M45,118,440
24≈ 54.07M54,073,668
25≈ 79.17M79,174,076
26≈ 136.9M136,897,911
27≈ 82.09M82,090,214
28≈ 19.3M19,300,096
29≈ 8.85M8,852,200
30≈ 13.73M13,731,938
31≈ 3.6M3,604,006
All metric groups

Profitability & efficiency

Profitability & efficiency
Net margin≈ 9.72%9.71541629611287%Last 12 months
Return on equity (ROE)≈ 3.09%3.08630610280426%Fiscal year 2025Period end:
Return on assets (ROA)≈ 0.704%0.704463208019007%Fiscal year 2025Period end:

How to read this group

Margins relate profit to revenue; ROE relates profit to equity. Compare similar businesses and periods.

Definitions in the guide
RICH · Profitability & efficiency
IndicatorIndicator and periodPeriodValue
After-tax marginPeriod not specifiedPeriod not specified≈ 9.72%9.71541629611287%
Asset turnoverLatest available figureLatest available figure≈ 0.34×0.340411163346925×
Asset turnoverFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.371×0.371335636212366×
EBITDA marginLast 12 monthsLast 12 months≈ 28.31%28.3075154591809%
EBITDA marginFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 32.24%32.2434988159303%
Free cash flow marginLast 12 monthsLast 12 months≈ 0.558%0.5579610287790294%
Free cash flow marginFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -28.35%-28.345434254242598%
Gross marginLast 12 monthsLast 12 months≈ 53.7%53.6993987943363%
Gross marginReported figure 1Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 55.13%55.1261044693229%
Gross marginPeriod not specifiedPeriod not specified≈ 53.7%53.6993987943363%
Gross marginReported figure 2Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 55.13%55.12610446932289%
Net marginLast 12 monthsLast 12 months≈ 9.72%9.71541629611287%
Net marginFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.9%1.89710638926162%
Net marginPeriod not specifiedPeriod not specified≈ 9.72%9.71541629611287%
Net margin before discontinued operationsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.9%1.8971063892616165%
Operating marginReported figure 1Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 23.9%23.904620211993333%
Operating marginLast 12 monthsLast 12 months≈ 17.94%17.9449098553862%
Operating marginReported figure 2Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 23.9%23.9046202119933%
Operating marginPeriod not specifiedPeriod not specified≈ 17.94%17.9449098553862%
Pre-tax marginLast 12 monthsLast 12 months≈ 14.01%14.0113674523926%
Pre-tax marginPeriod not specifiedPeriod not specified≈ 14.01%14.011367452392602%
Return on assets (ROA)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.704%0.704463208019007%
Return on assets (ROA)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.31%3.30723616375945%
Return on assets (ROA)Period not specifiedPeriod not specified≈ 3.31%3.30723616375945%
Return on capital employed (ROCE)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 10.62%10.622392015576887%
Return on capital employed (ROCE)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 7.99%7.98725508186795%
Return on common equityLast 12 monthsLast 12 months≈ 13.21%13.2094706279257%
Return on common equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 3.09%3.08630610280426%
Return on equity (ROE)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 3.09%3.08630610280426%
Return on equity (ROE)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 13.21%13.2094706279257%
Return on equity (ROE)Period not specifiedPeriod not specified≈ 13.21%13.2094706279257%
Return on invested capital (ROIC)Last 12 monthsLast 12 months≈ 4.67%4.67307014931604%
Return on invested capital (ROIC)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.03%1.02869973060346%
Return on invested capital (ROIC)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 4.67%4.67307014931604%
Return on invested capital (ROIC)Period not specifiedPeriod not specified≈ 4.67%4.67307014931604%
Return on tangible assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.71%0.7096995629467026%
Return on tangible assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.76%3.755845268431895%
Return on tangible equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 5.42%5.4236424713064695%
Return on tangible equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 25.26%25.26041479998963%
Return on total capitalFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 11.05%11.0482146133163%
Return on total capitalQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 7.51%7.51043445763067%
ROE adjusted to book valueLast 12 monthsLast 12 months≈ 1.77%1.7705905427748143%
ROE adjusted to book valueFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.77%1.7705905427748143%

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Debt & liquidity

Debt & liquidity
Current ratio≈ 0.923×0.923434352467025×Quarter 2 · fiscal 2026Period end:
Quick ratio≈ 0.495×0.495347978728038×Quarter 2 · fiscal 2026Period end:
Debt / equity≈ 2.07×2.0663070843912004×Quarter 2 · fiscal 2026Period end:

How to read this group

Liquidity concerns near-term obligations; leverage concerns business financing. Read both alongside cash flow.

Definitions in the guide
RICH · Debt & liquidity
IndicatorIndicator and periodPeriodValue
Assets / equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 4.61×4.60563564279884×
Assets / equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.8×3.80288018053488×
Cash and short-term investments / current liabilitiesFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.128×0.12812538400543713×
Cash and short-term investments / current liabilitiesQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.036×0.03601790378678067×
Cash and short-term investments / debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.0623×0.06229648802909125×
Cash and short-term investments / debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.0159×0.015908419549676946×
Current ratioLatest available figureLatest available figure≈ 0.923×0.923434352467025×
Current ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.01×1.0061965778061×
Current ratioQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.923×0.923434352467025×
Current ratioPeriod not specifiedPeriod not specified≈ 0.923×0.923434352467025×
Debt / assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.585×0.584688016488067×
Debt / assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.543×0.5433531918695821×
Debt / equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 2.69×2.6928599686548003×
Debt / equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.07×2.0663070843912004×
Debt / equityPeriod not specifiedPeriod not specified≈ 2.07×2.0663070843912004×
Debt / revenueLast 12 monthsLast 12 months≈ 1.86×1.8554991883926222×
Debt / revenueFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.94×1.94422696170708×
Debt / total capitalFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.729×0.7292071704575871×
Debt / total capitalQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.674×0.673874803637202×
EBITDA interest coverageLast 12 monthsLast 12 months≈ 11,962.7×11,962.699322416167×
EBITDA interest coverageFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 19,479.83×19,479.831483278955×
EBITDA less CapEx interest coverageLast 12 monthsLast 12 months≈ 1,188.18×1,188.1802977736525×
EBITDA less CapEx interest coverageFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -6,420.91×-6,420.90638426084×
Effective interest rate on debtLast 12 monthsLast 12 months≈ 0.00285%0.002850972045186133%
Effective interest rate on debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.000964%0.0009637395396664968%
Long-term debt / assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.443×0.44276814782308394×
Long-term debt / assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.435×0.435458735365896×
Long-term debt / equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 1.66×1.6559973941637487×
Net debt / EBITDAFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 5.65×5.6541892691885165×
Net debt / EBITDAQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 6.45×6.4505171125407665×
Quick ratioLatest available figureLatest available figure≈ 0.495×0.495347978728038×
Quick ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.652×0.652045603275203×
Quick ratioQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.495×0.495347978728038×
Quick ratioPeriod not specifiedPeriod not specified≈ 0.495×0.495347978728038×
Shareholders’ equity / assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.217×0.21712529551996887×
Shareholders’ equity / assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.263×0.26295858731456245×
Sloan ratioLast 12 monthsLast 12 months≈ 5.33%5.327400564776321%
Sloan ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 12.24%12.237239149452508%
Total debt / EBITDAFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 6.03×6.0298262691842535×
Total debt / EBITDAQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 6.55×6.5547935178847805×
Zmijewski scoreLast 12 monthsLast 12 months≈ -0.277-0.2774743298874037
Zmijewski scoreFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.06740.06741530939047102

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Growth

Growth
Revenue · year-on-year change≈ 23.97%23.969340553552023%Last 12 months
Net income · year-on-year change≈ -19.05%-19.04911283555013%Last 12 months
Revenue · 5-year compound annual growth (CAGR)≈ 82.96%82.96013441109471%Period not specified

How to read this group

YoY compares with the same period a year earlier; QoQ with the previous quarter. These bases are not interchangeable.

Definitions in the guide
RICH · Growth
IndicatorIndicator and periodPeriodValue
Basic EPS · 5-year compound annual growth (CAGR)Period not specifiedPeriod not specified≈ 37.66%37.66445338123505%
Capital expenditure · source sign · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -6.09%-6.090519585853728%
Capital expenditure · source sign · year-on-year changeLast 12 monthsLast 12 months≈ -3.35%-3.354952485153489%
Capital expenditure · source sign · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 368.8%368.801947927874%
Capital expenditure · source sign · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -45.2%-45.196723231861064%
Common dividend per share · primary issue · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -40.13%-40.13030199532252%
Diluted EPS · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -140.89%-140.89138618516662%
Diluted EPS · year-on-year changeLast 12 monthsLast 12 months≈ -19.05%-19.049099030632735%
Diluted EPS · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -92.34%-92.33571888273909%
Diluted EPS · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -207.75%-207.75167524995902%
Diluted EPS change over 5 yearsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 394.43%394.4348490384296%
Diluted EPS growthFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -89.92%-89.917735052142%
Diluted EPS growthQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -207.75%-207.751675249959%
EBITDA · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 76.05%76.0460989600993%
EBITDA · year-on-year changeLast 12 monthsLast 12 months≈ 24.43%24.4346966971179%
EBITDA · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 32.48%32.47841139888391%
EBITDA · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.38%2.376409284201675%
Free cash flow · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 214.69%214.69045466423137%
Free cash flow · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -3,141.12%-3,141.1197911639897%
Gross profit · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 25.39%25.38895143184038%
Gross profit · year-on-year changeLast 12 monthsLast 12 months≈ 29.23%29.228160985916084%
Gross profit · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 6.16%6.164709203232393%
Gross profit · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 12.6%12.600303539693423%
Net income · 5-year compound annual growth (CAGR)Period not specifiedPeriod not specified≈ 37.66%37.66422155376596%
Net income · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -140.89%-140.8913804581476%
Net income · year-on-year changeLast 12 monthsLast 12 months≈ -19.05%-19.04911283555013%
Net income · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -92.34%-92.33572863966984%
Net income · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -207.75%-207.75158436803457%
Revenue · 5-year compound annual growth (CAGR)Period not specifiedPeriod not specified≈ 82.96%82.96013441109471%
Revenue · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 14.1%14.103015230319327%
Revenue · year-on-year changeLast 12 monthsLast 12 months≈ 23.97%23.969340553552023%
Revenue · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 4.95%4.9453400868248805%
Revenue · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 30.26%30.264788196035752%
Revenue change over 5 yearsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1,950.13%1,950.1344961452617%
Total assets · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.39%2.3914032710908435%
Total assets · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 22.66%22.66368892112407%
Total assets · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 38.8%38.79786348174547%
Total debt · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.27%3.274649310039543%
Total debt · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 30.42%30.416992156438795%
Total debt · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 29.47%29.469173736524223%

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Dividends & buybacks

Dividends & buybacks
Dividend yield≈ 2.16%2.15981781456954%Latest available figure
Latest dividend per share≈ 16.51 ARS16.5144749 ARSPeriod not specified
Payment dateJun 16, 2026Period not specified

How to read this group

Separate past payments, upcoming payments and estimates. Yield depends on the price and dividend period.

Definitions in the guide
RICH · Dividends & buybacks
IndicatorIndicator and periodPeriodValue
Buyback yieldPeriod not specifiedPeriod not specified-0%
Cash dividend coverageLast 12 monthsLast 12 months≈ 12.24×12.2381116121101×
Cash dividend coverageFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 3.77×3.76685547521087×
Common dividend per share · primary issueFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 16.1 ARS16.098775 ARS
Consecutive years of dividend growthPeriod not specifiedPeriod not specified0
Consecutive years paying dividendsPeriod not specifiedPeriod not specified2
Dividend payout ratioLast 12 monthsLast 12 months0%
Dividend payout ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 54.07%54.073723880572%
Dividend payout ratio, %Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ 54.07%54.073723880572%
Dividend yieldLatest available figureLatest available figure≈ 2.16%2.15981781456954%
Dividend yieldFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.815%0.815127848101266%
Dividend yieldPeriod not specifiedPeriod not specified≈ 2.16%2.1598145695364237%
Dividends paid · source signPeriod not specifiedPeriod not specified≈ -2.63B ARS-2,630,975,214 ARS
Dividends paid · source signLast 12 monthsLast 12 months≈ -858.43M ARS-858,430,415 ARS
Dividends paid · source signFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -2.63B ARS-2,630,975,214 ARS
Dividends paid · source signQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -529.39M ARS-529,394,238 ARS
Dividends paid · source signHalf-yearHalf-year≈ -529.39M ARS-529,394,238 ARS
Ex-dividend datePeriod not specifiedPeriod not specifiedJun 12, 2026
Latest dividend per sharePeriod not specifiedPeriod not specified≈ 16.51 ARS16.5144749 ARS
Payment datePeriod not specifiedPeriod not specifiedJun 16, 2026
Share buyback ratioFiscal year 2025Period end: Fiscal year 2025Period end: 0%
Share buyback ratioQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0%

Choose an indicator to explore its history.

Financial year

Common dividend per share · primary issue

Dividends & buybacks

Common dividend per share · primary issueFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Common dividend per share · primary issue
Common dividend per share · primary issueARS
2025≈ 16.1 ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Common dividend per share · primary issue · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 16.1 ARS16.098775 ARS
2024≈ 26.89 ARS26.889688 ARS
20230 ARS
20220 ARS
2021≈ 1.62 ARS1.615315 ARS
2020≈ 0.555 ARS0.554739 ARS
20190 ARS
20180 ARS
All metric groups

Shares & workforce

Shares & workforce
Shares outstanding≈ 14.17M14,167,200Period not specified
Shares in public circulationNot availableLatest available figure
Number of employeesNot availablePeriod not specified

How to read this group

Shares outstanding, free float and voting rights are different concepts. Check the share class and date.

Definitions in the guide
RICH · Shares & workforce
IndicatorIndicator and periodPeriodValue
Diluted shares · FQQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 80.75M80,751,487
Shares outstandingLatest available figureLatest available figure≈ 14.17M14,167,200
Shares outstandingPeriod not specifiedPeriod not specified≈ 14.17M14,167,200
Shares outstanding · fundamental fieldPeriod not specifiedPeriod not specified≈ 14.17M14,167,200
Shares outstanding · provider-calculated fieldPeriod not specifiedPeriod not specified≈ 80.75M80,751,486.84900662

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Analyst expectations

Analyst expectations

How to read this group

An estimate is not a reported result. Before comparing, check the horizon, currency and per-share basis.

Definitions in the guide

Browse this group’s reported values or history.

No figures available yet

Missing data does not mean zero. You can explore another group.

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Price & market risk

Price & market risk
Beta · 1 year≈ 0.5070.5071303Period not specified
52-week price high2,300 ARSPeriod not specified
52-week price low1,045 ARSPeriod not specified

How to read this group

Beta describes historical sensitivity to an index; the 52-week range describes observed prices. Neither guarantees future prices.

Definitions in the guide
RICH · Price & market risk
IndicatorIndicator and periodPeriodValue
52-week price highPeriod not specifiedPeriod not specified2,300 ARS
52-week price lowPeriod not specifiedPeriod not specified1,045 ARS
Beta · 1 yearPeriod not specifiedPeriod not specified≈ 0.5070.5071303
Beta · 3 yearsPeriod not specifiedPeriod not specified≈ 0.7250.72481537
Beta · 5 yearsPeriod not specifiedPeriod not specified≈ 0.5860.5862437
Date of 52-week highPeriod not specifiedPeriod not specifiedDec 11, 2025
Date of 52-week lowPeriod not specifiedPeriod not specifiedOct 06, 2025

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Periods & calendar

Periods & calendar
Fiscal period endDec 31, 2025Financial year
Fiscal period endJun 30, 2026Quarter
Next earnings release · expected dateNot availablePeriod not specified

How to read this group

Fiscal period end, publication and retrieval are different dates. A fiscal year can end outside December.

Definitions in the guide

Additional information

RICH · Periods & calendar
IndicatorIndicator and periodPeriodValue
Fiscal periodLatest available figureLatest available figure2026-Q2
Fiscal periodFinancial yearFinancial year2025
Fiscal period endLatest available figureLatest available figureJun 30, 2026
Fiscal period endFinancial yearFinancial yearDec 31, 2025
Fiscal period endQuarterQuarterJun 30, 2026

Choose an indicator to explore its history.

Financial year

Historical fiscal-year identifiers

Periods & calendar

Historical fiscal-year identifiersFinancial year

Published fiscal-year identifiers, in their original order.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

RICH · Historical fiscal-year identifiers · Fiscal year
Position in seriesFiscal year
12025
22024
32023
42022
52021
62020
72019
82018
All metric groups

Additional information

Additional information

How to read this group

These fields have no verified classification. Retain the code, unit and context when interpreting them.

Definitions in the guide

Browse this group’s reported values or history.

No figures available yet

Missing data does not mean zero. You can explore another group.

Choose an indicator to explore its history.

No historical series are published for this selection.

Financial dataUpdated: Oct 03, 2026 · ARS

A view of the market.
With full transparency.

Closing prices and daily history from BYMA Open Data. These are not real-time quotes.

Quote sourceBYMA Open DataLatest available sessionOct 02, 2026Last fetchedOct 3, 2026, 04:27 AM GMT-3CurrencyARSSettlementT+1 · 24hsCoverage133 / 258

Daily history is kept as supplied by BYMA. Symbols without data show no quote. Dates may differ between stocks. Corporate-action adjustments are not independently verified.

Financial data

Financial statements, multiples and estimates. Availability varies by instrument. Profiles and shareholders show their sources and dates.

Last fetched: Oct 03, 2026

La Plata is independent. Commercial data publication requires reviewing BYMA terms.